Principal Investigator
Fangjian Zhou, MD
Sun Yat-sen University Cancer Prevention Center
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
DRUG(3)
MIXED(2)
Paclitaxel Injection
1 trial
phase_3
shanghai-miracogen-incMRG002
1 trial
phase_3
shanghai-miracogen-incPemetrexed Disodium Injection
1 trial
phase_3
shanghai-miracogen-incDocetaxel Injection
1 trial
phase_3
shanghai-miracogen-incGemcitabine Hydrochloride for Injection
1 trial
phase_3
shanghai-miracogen-inc5 unique interventions2 categories
Analytics
Trial Phases
Phase 31
Trial Status
Recruiting1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
Advanced or Metastatic Urothelium Cancer
Principalinvestigator
Research Network
Collaboration Network
3 collaborators·2 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Sun Yat-sen University Cancer Prevention Center
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
1 similar investigators found
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
Advanced or Metastatic Urothelium Cancer
All 1 trials loaded